Arteris powers AI and advanced chips with a high-margin royalty model, strong AMD ties, and over 50% upside despite GAAP ...

On August 4, Arteris Inc. (NASDAQ:AIP) announced that AMD licensed its FlexGen network-on-chip/NoC interconnect IP. This ...

Arteris shares are soaring in Monday's after-hours session after the company announced a deal with Advanced Micro Devices.

Arteris Inc (NASDAQ:AIP) is set to release its Q2 2025 earnings on Aug 5, 2025. The consensus estimate for Q2 2025 revenue is ...

Arteris, Inc. has announced that its FlexGen smart network-on-chip (NoC) IP will be deployed in AMD's next-generation AI ...

Q2 2025 Management View Karel Charles Janac, CEO, reported "record annual contract value plus royalties of $69.1 million" and highlighted exiting the quarter with $99.3 million in remaining ...

According to the two companies, AMD has licensed Arteris’ FlexGen NoC IP technology to support the development of its next ...

Investing.com -- Arteris Inc (NASDAQ: AIP) stock surged 45% in after-hours trading after the semiconductor system IP provider ...

AMD licenses Arteris's FlexGen network-on-chip (NoC) interconnect IP for its next generation of AI chiplet designs.

Arteris's AIP +38.3% Get Free Report short percent of float has risen 45.89% since its last report. The company recently reported that it has 943 thousand shares sold short, which is 4.61% of all ...

Arteris, Inc. (Nasdaq: AIP), a provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, - Read more from Inside HPC & AI News.

Arteris Plus supplements work instantly upon ingestion. This is due to the potent blend of the ingredients, which have been proven to protect against rising high blood pressure.